ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

BSGM BioSig Technologies Inc

2,01
-0,02 (-0,99%)
01 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BioSig Technologies Inc BSGM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,02 -0,99% 2,01 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,09 1,91 2,2599 2,01 2,03
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/5/202422:05GLOBEBioSig Announces Closing of $3 Million Registered Direct..
30/5/202417:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/5/202414:00GLOBEBioSig Announces $3 Million Registered Direct Offering..
28/5/202423:20EDGAR2Form 8-K - Current report
21/5/202417:10GLOBEBioSig Technologies Chief Executive Officer Mr. Anthony..
21/5/202417:08EDGAR2Form 8-K - Current report
20/5/202420:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/5/202422:20EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
07/5/202419:49EDGAR2Form 8-K - Current report
07/5/202414:00EDGAR2Form 8-K - Current report
03/5/202418:22GLOBEBioSig Technologies, Inc. Announces New Appointments to its..
30/4/202420:03GLOBEBioSig Technologies, Inc. Appoints Mr. Anthony Amato to..
04/4/202417:35GLOBEBioSig Engages Consulting Firm for Business Model Strategies
11/3/202414:00EDGAR2Form 8-K - Current report
05/3/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:00EDGAR2Form 8-K - Current report
20/2/202416:00GLOBEBioSig Announces Reduction of its Workforce
14/2/202421:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202414:35EDGAR2Form 8-K - Current report
06/2/202414:30GLOBEBioSig’s PURE EP™ Platform with New Near Field Tracking..
02/2/202423:18EDGAR2Form 8-K/A - Current report: [Amend]
01/2/202423:25EDGAR2Form 8-K - Current report
31/1/202422:05EDGAR2Form 8-K - Current report
31/1/202417:15GLOBEBioSig Announces Reverse Stock Split
30/1/202414:52EDGAR2Form 8-K - Current report
30/1/202414:30GLOBEBioSig Announces Cost Reductions to Improve its Financial..
16/1/202422:15EDGAR2Form D - Notice of Exempt Offering of Securities
12/1/202423:28EDGAR2Form 8-K - Current report
08/1/202417:00EDGAR2Form 8-K - Current report
05/1/202422:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
04/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202319:37EDGAR2Form DEL AM - Delaying amendment
28/12/202322:30EDGAR2Form 8-K - Current report
28/12/202322:05EDGAR2Form S-3 - Registration statement under Securities Act of..
22/12/202322:30EDGAR2Form 8-K - Current report
18/12/202322:36EDGAR2Form 8-K - Current report
06/12/202323:07EDGAR2Form 8-K - Current report
06/12/202320:20GLOBEBioSig Issues Letter to Shareholders Detailing Technology..
05/12/202323:29EDGAR2Form 8-K - Current report
05/12/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:13EDGAR2Form DEF 14A - Other definitive proxy statements
21/11/202323:32EDGAR2Form PRE 14A - Other preliminary proxy statements
14/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:02EDGAR2Form 8-K - Current report
13/11/202322:30GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
13/11/202314:35EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
08/11/202322:05EDGAR2Form 8-K - Current report
07/11/202314:01EDGAR2Form 8-K - Current report